Surgery in Primary Hyperparathyroidism: Extensive Personal Experience

Journal of Clinical Densitometry

Volumn 16, Issue 1, 2013, Pages 54-59

  Van Udelsman, Brooks ^a   Udelsman, Robert ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Minimally invasive parathyroidectomy; Parathyroid surgery; Primary hyperparathyroidism

Indexed keywords

ADRENALIN; ANALGESIC AGENT; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SEDATIVE AGENT;

ANESTHESIA INDUCTION; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; ENDOTRACHEAL INTUBATION; FATIGUE; GENERAL ANESTHESIA; HEMATOMA; HUMAN; HYPOCALCEMIA; INTRAOPERATIVE PERIOD; LOCAL ANESTHESIA; MOOD CHANGE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PAIN; PARATHYROID ADENOMA; PARATHYROIDECTOMY; PATIENT MONITORING; PERSONAL EXPERIENCE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE INJURY; REGIONAL ANESTHESIA; SEDATION; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBTOTAL THYROIDECTOMY; SURGICAL PATIENT; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT INDICATION; VOCAL CORD DISORDER;

ADENOMA; ANESTHESIA, CONDUCTION; DIAGNOSTIC IMAGING; HUMANS; HYPERPARATHYROIDISM, PRIMARY; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RECURRENCE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873156755     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2012.11.007     Document Type: Article

References (55)

1. Mandl F. 1926 Therapeutisher versuch bein falls von osteitisis fibrosa generalisata mittles. Extirpation eines epithelkorperchen tumors. [Therapeutic treatment by case of osteitis fibrosa generalalista disease. Extirpation of glandula parathyreoidea.] 143:245-284.
2. Roth S.I., Wang C.A., Potts J.T. The team approach to primary hyperparathyroidism. Hum Pathol 1975, 6(6):645-648.
3. Carling T., Udelsman R. Focused approach to parathyroidectomy. World J Surg 2008, 32(7):1512-1517.
4. Starker L.F., Fonseca A.L., Carling T., Udelsman R. Minimally invasive parathyroidectomy. Int J Endocrinol 2011, 2011:206502.
5. Wang C.A. Surgical management of primary hyperparathyroidism. Curr Probl Surg 1985, 22(11):1-50.
6. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009, 94(2):335-339. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism.
7. Udelsman R., Pasieka J.L., Sturgeon C., et al. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94(2):366-372.
8. Okamoto T., Gerstein H.C., Obara T. Psychiatric symptoms, bone density and nonspecific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J 1997, 44(3):367-374.
9. Hasse C., Sitter H., Bachmann S., et al. How asymptomatic is asymptomatic primary hyperparathyroidism?. Exp Clin Endocrinol Diabetes 2000, 108(4):265-274.
10. Jorde R., Waterloo K., Saleh F., et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 2006, 253(4):464-470.
11. Prager G., Kalaschek A., Kaczirek K., et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery 2002, 132(6):930-935. discussion 935-936.
12. Mittendorf E.A., Wefel J.S., Meyers C.A., et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract 2007, 13(4):338-344.
13. Weber T., Keller M., Hense I., et al. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 2007, 31(6):1202-1209.
14. Roman S.A., Sosa J.A., Pietrzak R.H., et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 2011, 253(1):131-137.
15. Carling T. Multiple endocrine neoplasia syndrome: genetic basis for clinical management. Curr Opin Oncol 2005, 17(1):7-12.
16. Carling T., Udelsman R. Parathyroid tumors. Curr Treat Options Oncol 2003, 4(4):319-328.
17. Wei C.H., Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol 2012, 13(1):11-23.
18. Udelsman R., Lin Z., Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011, 253(3):585-591.
19. Lavely W.C., Goetze S., Friedman K.P., et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007, 48(7):1084-1089.
20. Harris B., Bailey D., Roach P., et al. Use of fusion imaging to localize an ectopic thoracic parathyroid adenoma. Ann Thorac Surg 2006, 82(2):719-721.
21. Mihai R., Simon D., Hellman P. Imaging for primary hyperparathyroidism-an evidence-based analysis. Langenbecks Arch Surg 2009, 394(5):765-784.
22. Coakley A.J., Kettle A.G., Wells C.P., et al. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989, 10(11):791-794.
23. Arbab A.S., Koizumi K., Toyama K., et al. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998, 39(2):266-271.
24. Hetrakul N., Civelek A.C., Stagg C.A., Udelsman R. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 2001, 130(6):1011-1018.
25. Cheung K., Wang T.S., Farrokhyar F., et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 2012, 19(2):577-583.
26. Erbil Y., Barbaros U., Yanik B.T., et al. Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope 2006, 116(4):580-585.
27. Sukan A., Reyhan M., Aydin M., et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med 2008, 22(2):123-131.
28. Erbil Y., Barbaros U., Tukenmez M., et al. Impact of adenoma weight and ectopic location of parathyroid adenoma on localization study results. World J Surg 2008, 32(4):566-571.
29. Dy B.M., Richards M.L., Vazquez B.J., et al. Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not?. Ann Surg Oncol 2012, 19(7):2272-2278.
30. Kettle A.G., O'Doherty M.J. Parathyroid imaging: how good is it and how should it be done?. Semin Nucl Med 2006, 36(3):206-211.
31. Nichols K.J., Tomas M.B., Tronco G.G., Palestro C.J. Sestamibi parathyroid scintigraphy in multigland disease. Nucl Med Commun 2012, 33(1):43-50.
32. van Ginhoven T.M., Morks A.N., Schepers T., et al. Surgeon-performed ultrasound as preoperative localization study in patients with primary hyperparathyroidism. Eur Surg Res 2011, 47(2):70-74.
33. Untch B.R., Adam M.A., Scheri R.P., et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg 2011, 212(4):522-529. discussion 529-531.
34. Berber E., Parikh R.T., Ballem N., et al. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery 2008, 144(1):74-79.
35. Rodgers S.E., Hunter G.J., Hamberg L.M., et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 2006, 140(6):932-940. discussion 940-941.
36. Starker L.F., Mahajan A., Bjorklund P., et al. 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol 2011, 18(6):1723-1728.
37. Mahajan A., Starker L.F., Ghita M., et al. Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism. World J Surg 2011, 36(6):1335-1339.
38. Abbott D.E., Cantor S.B., Grubbs E.G., et al. Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost?. J Am Coll Surg 2012, 214(4):629-637.
39. Udelsman R., Aruny J.E., Donovan P.I., et al. Rapid parathyroid hormone analysis during venous localization. Ann Surg 2003, 237(5):714-719. discussion 719-721.
40. Perrier N.D., Ituarte P., Kikuchi S., et al. Intraoperative parathyroid aspiration and parathyroid hormone assay as an alternative to frozen section for tissue identification. World J Surg 2000, 24(11):1319-1322.
41. Greene A.B., Butler R.S., McIntyre S., et al. National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 2009, 209(3):332-343.
42. Stojadinovic A., Shaha A.R., Orlikoff R.F., et al. Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg 2002, 236(6):823-832.
43. Westerdahl J., Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 2007, 246(6):976-980. discussion 980-981.
44. Irvin G.L., Prudhomme D.L., Deriso G.T., et al. A new approach to parathyroidectomy. Ann Surg 1994, 219(5):574-579. discussion 579-581.
45. Irvin G.L. American Association of Endocrine Surgeons. Presidential address: chasin' hormones. Surgery 1999, 126(6):993-997.
46. Irvin G.L., Sfakianakis G., Yeung L., et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 1996, 131(10):1074-1078.
47. Chen H., Pruhs Z., Starling J.R., Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 2005, 138(4):583-587. discussion 587-590.
48. Fraker D.L., Harsono H., Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. Long-term results. World J Surg 2009, 33(11):2256-2265.
49. Norman J., Lopez J., Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg 2012, 214(3):260-269.
50. Carling T., Donovan P., Rinder C., Udelsman R. Minimally invasive parathyroidectomy using cervical block: reasons for conversion to general anesthesia. Arch Surg 2006, 141(4):401-404. discussion 404.
51. Gold J.S., Donovan P.I., Udelsman R. Partial median sternotomy: an attractive approach to mediastinal parathyroid disease. World J Surg 2006, 30(7):1234-1239.
52. Wang T.S., Udelsman R. Remedial surgery for primary hyperparathyroidism. Adv Surg 2007, 41:1-15.
53. Prescott J.D., Udelsman R. Remedial operation for primary hyperparathyroidism. World J Surg 2009, 33(11):2324-2334.
54. Hessman O., Stalberg P., Sundin A., et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 2008, 32(5):774-781. discussion 782-783.
55. Udelsman R. Unilateral neck exploration under local or regional anesthesia. Minimally Invasive Endocrine Surgery 2002, 93-101. Lippincott Williams & Wilkins, Pennsylvania, PA. M. Gagner (Ed.).